Bionure Farma, S.L.
Latest round
- Series A
Last raised
- May 2018
Total raised
- $4.7M
Investors
- 1
About Bionure Farma, S.L.
L. researches and develops the neuroprotectant BN201, which is a small molecule that induces remyelination of the neuron for the treatment of various neurological diseases.
Who invested in Bionure Farma, S.L.
1 investor across 1 round
See all investors in Bionure Farma, S.L.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 14, 2018
Amount
$4.7M
Investors
Questions about Bionure Farma, S.L.
Who invested in Bionure Farma, S.L.?
Bionure Farma, S.L. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bionure Farma, S.L. raised?
Bionure Farma, S.L. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bionure Farma, S.L. last raise money?
Bionure Farma, S.L.'s most recent round on record is a Series A, in May 2018.
What does Bionure Farma, S.L. do?
Bionure Farma, S.L. is a pharmaceuticals company.
Where is Bionure Farma, S.L. headquartered?
Bionure Farma, S.L. is headquartered in Barcelona, Spain.
Which VCs invest in companies like Bionure Farma, S.L.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Bionure Farma, S.L.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Bionure Farma, S.L.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.